Buy Target – $1.85 or better Sell Target – TradersPro Sell Signal Genprex, Inc. operates as a clinical-stage gene therapy company. The company engages in developing technologies for cancer patients based upon a proprietary technology platform. Its platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which […]
Read MorePlus, the coronavirus finally has a name, Carnival Cruise Line said that the virus outbreak could dent full-year earnings, and Nissan is suing former Chairman Carlos Ghosn.
Read MoreOne of the interesting things about investing is the way emotion often drives the rotation of money from one sector or industry into another. While the market in the broadest sense appears to be shrugging off coronavirus-related uncertainty, stocks in the Energy sector have struggled. That includes stocks in the Oil & Gas Transportation industry, […]
Read MoreTrade Setup Buy Target $2.48 Sell Target $3.04 DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers […]
Read MoreBuy Target – $112.30 or better Sell Target – TradersPro Sell Signal Generac Holdings Inc. designs, manufactures, and sells power generation equipment and other power products for the residential, light commercial, and industrial markets worldwide. The company offers engines, alternators, transfer switches, and other components fueled by natural gas, liquid propane, gasoline, diesel, and bi-fuel. […]
Read MorePlus, Fed Chairman Jerome Powell said the central bank is “closely monitoring” the effects of the coronavirus outbreak, and Under Armour shares are sinking after athletic apparel maker said it expects low-single digit sales growth this year.
Read MoreLast month, media buzz related to the ongoing, drawn-out grounding of the Boeing 737 Max prompted me to take a serious look at airline carriers to evaluate their exposure to risk resulting from that issue. That’s because continued delays in the 737 Max have forced airline carriers to cancel flights on a widespread basis and […]
Read MoreTrade Setup Buy Target $119.01 Sell Target $128.97 Cimpress plc provides various mass customization services in North America, Europe, Australia/New Zealand, South America, and the Asia Pacific regions. The company operates through five segments: Vistaprint, PrintBrothers, The Print Group, National Pen, and All Other Businesses. It provides printed and digital marketing products; Internet-based canvas-print wall […]
Read MorePlus, Simon Property Group is acquiring Taubman Centers for $3.6 billion, and Eli Lilly shares are down after a failed trial for its Alzheimer’s drug candidate.
Read MoreBuy Target – $24.00 or better Sell Target – TradersPro Sell Signal Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total […]
Read MoreThe market’s rally to a new set of all-time highs is being taken as a sign that the economy is going to continue to grow throughout the rest of the year, which also means that for a many analysts and investors, the market is expected to maintain its long-term upward trend. The news hasn’t been […]
Read MoreBuy Target – $7.25 or better Sell Target – TradersPro Sell Signal Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates through two segments, Proprietary Products and Distribution. The company offers respiratory products, including Glassia for use in augmentation and maintenance therapy in adults with emphysema due to congenital Alpha-1 […]
Read MorePlus, the U.S. economy added 225,000 jobs in January, and Myriad Genetics shares are in free fall after it significantly missed on earnings.
Read MoreThe signing of Phase One of a trade deal between the U.S. and China in January gave the market a renewed sense of optimism that long-term trade peace is on the horizon. While this week the market has been rattled by the coronavirus, indications this week suggest that while its impact, particularly in China will […]
Read MoreRecent weakness is presenting a buying opportunity for this chipmaker – and it could see double-digit upside just ahead.
Read More